Agilis RF TSP Early Feasibility Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Agilis RF TSP Early Feasibility Study — Stella

Home/Cardiac Arrythmias/

View on ClinicalTrials.gov

Recruiting

Back to Cardiac Arrythmias trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Arrhythmia Research Group (St. Bernards), Jonesboro, Arkansas

California Pacific Medical Center -Van Ness Campus, San Francisco, California

Key details

Sponsor

Abbott Medical Devices

Enrollment target

~20 participants

Started

February 2026

Primary completion

June 2026

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.